my wife subscribes to 'Real Simple' magazine, and there are always numerous one-page ads touting facial creams...mainly for wrinkles and anti-aging. the ad redundancy leads me to believe the ads are working for them, especially since the mag readership is primarily women. I like that one can focus and linger upon a print ad in a mag (especially for those who have a need), and before and after pics could be shown. anatabloc crème is definitely more expensive than the others being advertised in this mag and others, though, which moves me believe: that anatabloc crème works where others have failed, it can treat conditions (not merely wrinkles and such), and that rock creek will probably want to sell the crème as a prescription crème, both to warrant the higher price and effectiveness.
it's unfortunate...it all could have possibly been avoided if he had merely disclosed the gifts when received.
points to take from this:
1. uphold integrity no matter what...even if no one will ever see or know (SOMEONE ALWAYS sees).
2. it's easy to point a finger, but it's also easy to make a small compromise, and then have it compounded.
3. wise decision to change ceo, company name, symbol, and location.
4. the media finally got it right...star is a pharmaceutical company!
ahh, so you admit mullan believes he may possibly strike it rich with star. finally, you admit the great potential in star. welcome to the club.
actually, you are wrong. imagine that. if you watch dr michael mullah's youtube videos on his alzheimer's research, you will see that he discusses his research on nilvad, and then immediately follows with his research on anatabine, and how they could potentially work together.
and you're certain the nilvad study won't work? you're funny.
Anatabloc clinical study:
Primary completion date was Dec 2013...now changed to Dec 2014
other key study:
Phase 3 clinical study with Nilvadipine to treat Alzheimer's:
Study date: Oct 2012
Estimated Study Completion Date: Dec 2017
Estimated Primary Completion Date: May 2016 (final data collection date for primary outcome measure)
at only a dollar now, i can picture a potential fifty bucks per share being worth the wait. also,
'I can picture in my mind a world without war, a world without hate. And I can picture us attacking that world because they'd never expect it.' -- Deep Thoughts by jack handy
JW shows confidence in anatabine...in Mullan...in Rock Creek.
Dr. Mullan: "If you make more amyloid, you make more Alzheimer's...When you add anatabine, you really suppress that effect very dramatically, so anatabine has the ability to suppress the pro-inflammatory, but also the pro-Alzheimer's effect in human neurons...with anatabine, you can see this reduction in amyloid production."
Nilvad clinical currently recruiting in 23 hospitals/universities in Greece, Italy, France, Germany, Hungary, Ireland, Netherlands, Sweden, and UK.
"If this trial is successful, Nilvadipine would represent an advance in the treatment of Alzheimer's Disease patients and would have a major impact on the health and social care costs incurred by this neurodegenerative disorder."
roskamp institute and archer pharmaceuticals adjoined (possibly rock creek before long):
'Time is not money! Time has the potential to make someone money.'
agreed. i've also had a problem with the saying, 'Perception is reality.' i get what it's referring to and all, but perceptions are very often flat out wrong! i had a long debate with a gentleman once about this. he insisted that if people perceive something, THAT is reality. i see his point, but i argued that it's still not reality...the perception is merely wrong. they may act upon the wrong perception, but that doesn't make something not real, real. no sale. when people believed the earth to be flat, that did not become reality. when kids believe there to be a santa, there is still no santa. in their minds, perhaps, but the perception is wrong.
where's my coffee?
'Track 1 non-prescription = as is today'
true, and yet even better with time-released version for improved regulation, fewer doses, and better efficiency with increased strength. much greater market acceptance!
the anatabine and nilvadipine cocktail ~ Anadipine
nilvadipine currently in Phase III with 500 patients in nine countries. nilvadipine crosses the blood brain barrier, getting from the blood to the brain and accumulating in the brain.
dr michael mullan: 'There are very, very few compounds in Phase III clinical trials for Alzheimer's, certainly less than the number of fingers on two hands.'
certainly LESS THAN TEN compounds (if i counted correctly)!
interesting to note that Hopkins thanks Michael Mullan and Fiona Crawford for THEIR guidance and advice!
after searching for "anatabine" on the Hopkins medicine site, click on "Research at Johns Hopkins Medicine", and it takes you to Publications for November 2012. if you then click on the third one down, it takes you to the study which includes:
"Anatabine source and administration
Anatabine was provided by Rock Creek Pharmaceuticals (Washington, DC), its commercial producer."
We express our gratitude to Drs. Michael Mullan and Fiona Crawford (Roskamp Institute, Sarasota, FL) for their guidance and advice.
This work was supported by a grant from the Walton Family Foundation. S.I. was supported in part by a fellowship from the Uehara Memorial Foundation (Tokyo, Japan).
Disclosure Summary: P.C. and P.W.L. are consultants for Rock Creek Pharmaceuticals Inc."
the BloombergBusinessWeek article is titled: "FDA Warns Against Concussion-Curing Claims on Supplements" ~ where does star claim anatabloc will CURE concussions? i've yet to see that...anywhere.
the article begins:
"If you’ve sustained a concussion—a brain injury from head trauma that can manifest in such symptoms as headaches, confusion, and amnesia—doctors recommend lots of rest. Taking dietary supplements to accelerate recovery or prevent traumatic brain injury won’t help, they say." ~ lots of rest...yes, good advice. but the second sentence? supplements 'won't help, they say'. really? stated as fact? from what clinical testing did they glean and justify this factual wisdom?
to me, that's worse than suggesting 'a supplement may potentially help treat a concussion, etc.'
"At issue are company press releases regarding studies done by Johns Hopkins University researchers when in fact the researchers were paid company consultants."
so, the studies were not done by johns hopkins university researchers. they were done by paid company consultants who were johns hopkins university researchers.
great, I'm glad we cleared that up. let's move on.